MedPath

涛生制药有限公司

Ownership
-
Established
2005-02-17
Employees
-
Market Cap
-
Website
http://www.a-hospital.com/w/安徽济丰药业有限公司

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

25

NMPA:25

Drug Approvals

Tetracycline Tablets

Product Name
四环素片
Approval Number
国药准字H34020029
Approval Date
Jun 24, 2020
NMPA

Prednisone Acetate Tablets

Product Name
醋酸泼尼松片
Approval Number
国药准字H34020009
Approval Date
Jun 24, 2020
NMPA

Lincomycin Hydrochloride Capsules

Product Name
盐酸林可霉素胶囊
Approval Number
国药准字H34020038
Approval Date
Jun 24, 2020
NMPA

Doxazosin Mesylate

Product Name
甲磺酸多沙唑嗪
Approval Number
国药准字H20031083
Approval Date
Jun 24, 2020
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H34020019
Approval Date
Jun 24, 2020
NMPA

Tetracycline Tablets

Product Name
四环素片
Approval Number
国药准字H34020030
Approval Date
Jun 24, 2020
NMPA

Metoclopramide Tablets

Product Name
甲氧氯普胺片
Approval Number
国药准字H34020020
Approval Date
Jun 24, 2020
NMPA

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H34020012
Approval Date
Jun 24, 2020
NMPA

Ephedrine Hydrochloride Tablets

Product Name
盐酸麻黄碱片
Approval Number
国药准字H34020027
Approval Date
Jun 24, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H34020017
Approval Date
Jun 24, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.